Skip to main content


Showing posts from April 20, 2008

Possible NHL-MCL Vaccine is Near

As we approach 250 days post-SCT (Monday, April 28), we found this good news about the possible development of a vaccine for mantle cell lymphoma for thos so afflicted:

[ALTACITIES.COM] ... About BiovaxID
®: BiovaxID is a personalized, patient-specific therapeutic vaccine designed to stimulate the patient's own immune system to recognize and destroy cancerous B-cells that may remain in the body or may arise after the patient has been treated with chemotherapy. Unlike many other approaches to treating non-Hodgkin's lymphoma, BiovaxID is designed to kill only cancerous B-cells, with the initial indication of follicular Non-Hodgkin's lymphoma. Additionally, we anticipate that BiovaxID could potentially be used to treat other types of B-cell cancers, such as Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma. @ltaLINK To This SOURCE